CMA
IBB icon

Cedar Mountain Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Cedar Mountain Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31
Closed -$4K – 260
2020
Q2 		$4K Hold
31
– – ﹤0.01% 188
2020
Q1 		$3K Hold
31
– – ﹤0.01% 184
2019
Q4 		$4K Buy
+31
New +$3.46K ﹤0.01% 184

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cedar Mountain Advisors's IBB Position: Q3 2020 in Review

Cedar Mountain Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 31 shares — an estimated $4K sold.

Cedar Mountain Advisors first reported a position in IBB in Q4 2019 and held it in 3 quarters. The position peaked at $4K in Q2 2020. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

  • Cedar Mountain Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
  • Cedar Mountain Advisors sold 31 iShares Biotechnology ETF shares in Q3 2020, an estimated $4K.
  • Cedar Mountain Advisors first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 3 quarters.
  • Cedar Mountain Advisors's iShares Biotechnology ETF position peaked at $4K in Q2 2020.
  • 784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Cedar Mountain Advisors's 13F filing for Q3 2020, filed 21 Oct 2020.